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CASE REPORT 
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Departments ofVascular Surgery and *Haematology, The General Infirmary at Leeds, Great George Street, 
Leeds LS1 3EX, U.K. 
A 58-year-old man presented acutely to the emergency 
department with a 48h history of pain in both hands. 
The pain was of sudden onset, and had rapidly in- 
creased in intensity, such that he had been unable to 
sleep. He also described claudication i his right calf 
at 100m over the last year. He had lost 6kg in weight 
over the last year, and had been investigated 1 year 
ago for a mass in the left side of his neck. He had 
been discharged from follow-up, with no definitive 
treatment. His only cardiovascular risk factor was a 
consumption of 20 cigarettes per day for 40 years. 
Importantly, there was no prior history of vasospasm, 
dehydration, cold exposure, connective tissue disorder 
or ergot ingestion, and he had not suffered from any 
recent illnesses. 
On examination, he was in severe pain, with grossly 
ischaemic hands. All of his right fingers were purple, 
with absent sensation and capillary refill to the level 
of the metacarpophalangeal joints. The radial pulse 
was absent, and the ulnar pulse was just palpable. On 
the left side, the tip of the index finger and thumb 
were discoloured, with diminished capillary refill, but 
normal sensation. A good radial pulse was palpable. 
The remainder of the upper limb pulses were normal, 
with no bruits. In the lower limbs the left great toe 
was discoloured and cool, but retained normal ca- 
pillary refill and sensation. The dorsalis pedis pulse 
was absent bilaterally, but the rest of the lower limb 
pulses were normal. 
Examination of the cardiac, respiratory and ab- 
dominal systems revealed no abnormality. 
Intravenous access was established, and morphine 
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administered. In addition, a bolus of 5000 units of 
heparin was given for immediate anticoagulation. Via 
the right common femoral artery, arteriography was 
performed. This revealed a normal aortic arch, with 
normal proximal vessels to the right arm. However 
there was abrupt occlusion of both the radial and ulnar 
arteries at the right wrist, with very poor supply to 
the hand. On the left side the major vessels were again 
normal, with the radial artery occluded at the level of 
the palmar arch, and segmental occlusions of the 
digital vessels. The ulnar artery remained patent. In 
the lower limbs there was a single patent posterior 
tibial artery to the left foot, with normal vessels on 
the right. As the right hand was most severely affected, 
a 6-French gauge catheter was placed in the right 
brachial artery, and streptokinase infused at a rate of 
25 000 units per hour for 20h. In addition, heparin, at 
a rate of 1000 units per hour, was infused down the 
catheter sheath. The activated partial thromboplastin 
time (APTT) was maintained between three and four 
times control. After 20h of streptokinase, the vas- 
cularity of the hand was much improved, sensation 
had returned and capillary refill, though sluggish, 
was present. An echocardiogram was performed and 
excluded endocarditis, atrial myxoma nd intracardiac 
thrombus. A full blood count revealed levels of haemo- 
globin, packed cell volume, white cell and platelet 
counts all within the normal range. A thrombophilia 
screen was performed (with the patient on intravenous 
heparin, but not yet commenced on warfarin) and 
revealed low levels of anti-thrombin III (50% - normal 
range 80-120, Instrumentation Laboratory Chro- 
magenic Assay) and protein C (63% - normal range 
70-149, Chromagenix, Chromagenic Assay). Protein S 
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and fibrinogen levels were normal, and lupus anti- 
coagulant and anti-cardiolipin antibodies were neg- 
ative. Furthermore, there was no evidence of 
paraproteinaemia. As the patient was on heparin ther- 
apy, the low level of anti-thrombin III may represent 
artifact. The abnormal protein C result may, however, 
be a tumour-related acquired deficiency. 
Upon reviewing the medical notes, it was discovered 
that a referral had been made to the Ear, Nose and 
Throat Department some 14 months before by the 
patient's general practitioner, for a persistently en- 
larged left jugulodigastric lymph node. Fine needle 
aspiration cytology had been undertaken at this time, 
but yielded no cells. A flexible laryngoscopy was 
attempted, but proved unsuccessful. A computerised 
tomography (CT) scan was performed, and reported 
as showing a supraglottic tumour arising from the left 
piriform fossa, with a large necrotic lymph node mass 
within the anterior jugulodigastric hain of nodes. 
A direct laryngoscopy was performed under general 
anaesthetic, but no lesion was seen. He was reviewed 
in ENT outpatients at 2 months, where the node was 
said to be resolving, and he was discharged from 
follow-up. A second referral to the ENT department 
was made by the GP just prior to this acute admission, 
and a second FNAC was performed. This was reported 
as showing no malignant cells, but the smear showed 
a non-specific picture, which may be unrepresentative 
of the lesion. A second CT scan was requested, but 
was pre-empted by his acute admission. 
The patient was re-examined, and a firm, smooth, 
non-tender left jugulodigastric node, measuring 
3 x 3cm, was discovered just below the angle of the 
left jaw. FNAC was performed and revealed sheets 
of carcinomatous cells, it was unclear whether these 
represented adeno or squamous carcinoma. A series 
of investigations was performed. At upper gastro- 
intestinal endoscopy, the scope could not pass beyond 
the upper oesophagus. A subsequent barium swallow 
was, however, normal. The ENT surgeons performed 
a laryngoscopy and rigid bronchoscopy, both of which 
revealed no abnormality. A chest radiograph and ultra- 
sound scan of the abdomen were also normal. 
Throughout this period, the hands continued to 
improve. The patient was given intravenous iloprost 
and heparin, and oral warfarin and nicardipine were 
commenced. Despite regular opiates, the right hand 
remained very painful. Upon the advice of the pain 
team, a right stellate ganglion block (bupivicaine and 
depomedrone) was performed and two injections of 
intra-arterial guanethidine were administered into the 
right brachial artery. Together, these produced a good 
result. The stellate ganglion block, however, did not 
clinically improve the temperature or colour of the 
right hand. 
After discharge, the patient remained well. The fin- 
gertips of the right thumb, index and middle fingers 
were affected by dry gangrene. They remained free 
from infection and painless, and auto-amputation is 
anticipated. All the fingers of the left hand are viable. 
Discussion 
A prothrombotic state is common in patients with 
malignant disease. 1 Several factors are responsible for 
the increased coagulation. Tumours have been shown 
to produce two principal procoagulants - tissue factor 
(TF) and cancer procoagulant (CP). 2'3 The former acts 
as a co-factor to factor VIIa for activation of factor X, 
whilst CP directly activates factor X. In addition to their 
effects on clotting factors, tumour cells also activate 
platelets in vitro, 4 at least in part by increased adenosine 
diphosphate r lease (ADP), 5'6'7 and this effect on plate- 
let activation may be important in vivo. Decreased 
levels of antithrombin III, 8-11 protein C9 "11-13 and protein 
S, ~3 and increased levels of plasminogen activator in- 
hibitor activity, ~4-~6 circulating fibrin monomers ~a and 
von Willebrand factor ~6'18 have also been reported in 
cancer patients. In the context of malignancy, these 
represent acquired disorders. In fact a large number 
of haemostatic abnormalities have been reported in 
many patients with cancer. A reduction in the naturally 
occurring anticoagulants tip the physiological balance 
further towards thrombosis, and this is reflected in 
activation of the coagulation system, with con- 
sumption and regeneration of coagulation factors, and 
compensatory fibrinolysis. 
The most common thromboembolic complications 
in cancer patients are deep venous thrombosis and 
pulmonary embolism. 19 Arterial thrombosis has been 
less commonly reported. 2°'2~ Our case illustrates wide- 
spread arterial thrombosis in a patient with metastatic 
carcinoma. The difficulty in establishing the primary 
site is not in itself unusual. However, aggressive treat- 
ment with both locally directed thrombolysis and sys- 
temic anticoagulation prevented further tissue loss. 
In addition, a multidisciplinary approach, with early 
involvement of a dedicated pain team, yielded ex- 
cellent results. The low level of protein C may be 
attributable to tumour activity, whereas the low level 
of the anti-thrombin III may represent the effects of 
heparin. As he has no living relatives, it was not 
possible to perform a thrombophilia screen to exclude 
an inherited disorder. Despite an occult primary neo- 
plasm, the patient continues to be well. 
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